(Q42250954)

19 October 2017

title

Von Willebrand Factor as a new marker for non-invasive assessment of liver fibrosis and cirrhosis in patients with chronic hepatitis C. (English)

1 reference

19 October 2017

0 references

1 reference

A Maieron

1

1 reference

19 October 2017

P Salzl

2

1 reference

19 October 2017

M Peck-Radosavljevic

3

1 reference

19 October 2017

M Trauner

4

1 reference

19 October 2017

S Hametner

5

1 reference

19 October 2017

R Schöfl

6

1 reference

19 October 2017

P Ferenci

7

1 reference

19 October 2017

M Ferlitsch

8

1 reference

19 October 2017

language of work or name

English

0 references

publication date

5 December 2013

1 reference

Alimentary Pharmacology & Therapeutics

19 October 2017

published in

1 reference

19 October 2017

volume

39

1 reference

19 October 2017

issue

3

1 reference

19 October 2017

page(s)

331-338

1 reference

The global burden of hepatitis C

19 October 2017

cites work

1 reference

Global epidemiology of hepatitis C virus infection

21 January 2018

1 reference

The natural history of hepatitis C.

21 January 2018

1 reference

Surveillance of cirrhosis for hepatocellular carcinoma: a cost-utility analysis

21 January 2018

1 reference

Telaprevir for previously untreated chronic hepatitis C virus infection

21 January 2018

1 reference

Boceprevir for untreated chronic HCV genotype 1 infection

21 January 2018

1 reference

Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890.

21 January 2018

1 reference

Non invasive fibrosis biomarkers reduce but not substitute the need for liver biopsy

21 January 2018

1 reference

Bleeding complications after percutaneous liver biopsy. An analysis of risk factors.

21 January 2018

1 reference

Treatment of chronic hepatitis C genotype 1 patients at an academic center in Europe involved in prospective, controlled trials: is there a selection bias?

21 January 2018

1 reference

Noninvasive methods to assess liver disease in patients with hepatitis B or C.

21 January 2018

1 reference

A comparison of four fibrosis indexes in chronic HCV: development of new fibrosis-cirrhosis index (FCI)

21 January 2018

1 reference

Standardization of factor VIII and von Willebrand factor in plasma: calibration of the WHO 5th International Standard (02/150).

21 January 2018

1 reference

von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.

21 January 2018

1 reference

Platelets mediate cytotoxic T lymphocyte-induced liver damage

21 January 2018

1 reference

Vascular endothelial dysfunction in cirrhosis

21 January 2018

1 reference

von Willebrand factor antigen: a novel on-treatment predictor of response to antiviral therapy in chronic hepatitis C genotypes 1 and 4.

21 January 2018

1 reference

Peginterferon alfa-2a/ribavirin for 48 or 72 weeks in hepatitis C genotypes 1 and 4 patients with slow virologic response

21 January 2018

1 reference

Long-term follow-up of chronic hepatitis C patients with sustained virological response to various forms of interferon-based anti-viral therapy

21 January 2018

1 reference

Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF).

21 January 2018

1 reference

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

21 January 2018

1 reference

Short- and long-term effects of therapy with interferon-alpha and pegylated interferon-alpha/ribavirin on platelet plug formation and von Willebrand factor release in patients with chronic hepatitis C.

21 January 2018

1 reference

Development of a novel score for liver fibrosis staging and comparison with eight simple laboratory scores in large numbers of HCV-monoinfected patients.

21 January 2018

1 reference

Non-invasive markers for hepatic fibrosis

21 January 2018

1 reference

Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model

21 January 2018

1 reference

Transient elastography for the noninvasive assessment of liver fibrosis: a multicentre Canadian study

21 January 2018

1 reference

Sampling variability of liver fibrosis in chronic hepatitis C.

21 January 2018

1 reference

Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C.

21 January 2018

1 reference

Discordance among transient elastography, aspartate aminotransferase to platelet ratio index, and histologic assessments of liver fibrosis in patients with chronic hepatitis C.

21 January 2018

1 reference

Assessment of liver fibrosis before and after antiviral therapy by different serum marker panels in patients with chronic hepatitis C.

21 January 2018

1 reference

A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

21 January 2018

1 reference

Reduced Mortality Rates Following Elective Percutaneous Liver Biopsies

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/APT.12564

1 reference

19 October 2017

1 reference